Effect of risedronate on bone loss at discontinuation of denosumab

PURPOSE: The occurrence of multiple vertebral fractures was reported after denosumab discontinuation. The use of bisphosphonates following denosumab has been suggested to prevent this bone loss. The aim of our observational trial was to evaluate the ability of risedronate to prevent the bone loss re...

Descripción completa

Detalles Bibliográficos
Autores principales: Laroche, Michel, Couture, Guillaume, Ruyssen-Witrand, Adeline, Constantin, Arnaud, Degboé, Yannick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371752/
https://www.ncbi.nlm.nih.gov/pubmed/32715031
http://dx.doi.org/10.1016/j.bonr.2020.100290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371752/
https://www.ncbi.nlm.nih.gov/pubmed/32715031
http://dx.doi.org/10.1016/j.bonr.2020.100290

Ejemplares similares